Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Denis Bagneres"'
Autor:
Yves Frances, Denis Bagneres, Luc Xerri, Colette Taranger-Charpin, Lucile Andrac-Meyer, Anass Harket, Jean-Philippe Dales
Publikováno v:
Annales de Pathologie. 25:45-49
We report the case of a plasmablastic lymphoma involving the skin in a 45 year-old HIV-positive patient. Plasmablastic lymphoma was first described in 1997 and is considered to be a diffuse large B-cell lymphoma with a unique immunophenotype and a pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a968a2811a266f89f008ad5b6d22728f
https://doi.org/10.1016/s0242-6498(05)80098-7
https://doi.org/10.1016/s0242-6498(05)80098-7
Autor:
Yves Frances, Anne Laurence Demoux, F. Bernard, Denis Bagneres, Pascal Rossi, Laurent Bonello, Karim Aissi, Brigitte Granel
Publikováno v:
BMJ case reports. 2010
A 67-year-old woman, with no remarkable medical history, was admitted to emergency for a first time generalised seizure. Her physical examination was normal. The electroencephalogram (EEG) performed 12 h later revealed a generalised slowing pattern.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::206dc608a5469f9c9692ef55a43ab2be
https://pubmed.ncbi.nlm.nih.gov/22750926
https://pubmed.ncbi.nlm.nih.gov/22750926
Publikováno v:
BMJ case reports. 2009
Asplenic patients are highly susceptible to infections with encapsulated bacteria such as Capnocytophaga canimorsus, a gram negative bacillus which is a commensal organism in cat and dog saliva. We describe the first case of septic shock due to C can
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd57efaa6779b6e386aae51ed19477d3
https://pubmed.ncbi.nlm.nih.gov/21747901
https://pubmed.ncbi.nlm.nih.gov/21747901
Autor:
Yves Frances, Denis Bagneres, Pascal Rossi, Brigitte Granel, Anne Laurence Demoux, Isabelle Dettori, Pierre Lafforgue, F. Bernard, Régis Costello
Mixed warm and cold autoimmune anaemia is a rare haemolytic anaemia that is commonly associated with lymphoproliferative disorders and autoimmune diseases. Although steroid therapy is the first-line treatment, rituximab represents a good alternative.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::27bff4c7628df3d7edec18f473c8e0d0
https://europepmc.org/articles/PMC3028234/
https://europepmc.org/articles/PMC3028234/
